Cargando…
Treatment of Iron Deficiency Anemia in CKD and End-Stage Kidney Disease
Iron deficiency is common in individuals with chronic kidney disease and plays a major role in the development of anemia. Oral and intravenous iron agents are both available to replete iron in patients with chronic kidney disease diagnosed with iron deficiency. The choice of which agent to use is mo...
Autor principal: | Gutiérrez, Orlando M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418942/ https://www.ncbi.nlm.nih.gov/pubmed/34514189 http://dx.doi.org/10.1016/j.ekir.2021.05.020 |
Ejemplares similares
-
Iron-Deficiency Anemia in CKD: A Narrative Review for the Kidney Care Team
por: Hain, Debra, et al.
Publicado: (2023) -
Iron Deficiency in CKD Without Concomitant Anemia
por: Wish, Jay B., et al.
Publicado: (2021) -
Anemia and Iron Deficiency in Children with Chronic Kidney Disease (CKD): Data from the Know-Ped CKD Study
por: Lee, Keum Hwa, et al.
Publicado: (2019) -
Biomarkers of Kidney Tubule Disease and Risk of End-Stage Kidney Disease in Persons With Diabetes and CKD
por: Amatruda, Jonathan G., et al.
Publicado: (2022) -
Intravenous Iron Repletion Does Not Significantly Decrease Platelet Counts in CKD Patients with Iron Deficiency Anemia
por: Dossabhoy, Neville R., et al.
Publicado: (2013)